MIMEDX GROUP, INC.MDXG
Market cap
$1B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 1 | 2 | 6 | 11 | 17 | 18 | 15 | 12 | 15 | 15 | 13 | 17 | 17 |
| Cash from operations | -6,664,771 | -3,384,831 | -285,477 | 17 | 19 | 26 | 36 | -39 | -30 | -2 | -18 | 35 | 67 |
| Capital expenditures | - | - | - | - | - | - | - | - | - | - | - | -2 | - |
| Cash from investing | -702,508 | -582,931 | -3,025,414 | -12 | -1 | -12 | -9 | 1 | -5 | -3 | -3 | -2 | -10 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | - | 10 | - |
| Cash from financing | 10 | 7 | 41 | -2 | -36 | -8 | -9 | 63 | 62 | -3 | -1 | -9 | -34 |
| Free cash flow | - | - | - | - | - | - | - | - | - | - | - | - | |
| FCF margin (%) | - | - | - | - | - | - | - | - | - | - | - | - |